Administration of Bone Marrow-Derived Mononuclear Cells Contributed to the Reduction of Hypoxic-Ischemic Brain Injury in Neonatal Rats

Administration of Bone Marrow-Derived Mononuclear Cells Contributed to the Reduction of Hypoxic-Ischemic Brain Injury in Neonatal Rats

Background/Objective: Perinatal hypoxic-ischemia (HI) causes neonatal death and permanent neurological deficits. Cell therapy using various cell sources has been recently identified as a novel therapy for perinatal HI. Among the available types of cell sources, bone marrow-derived mononuclear cells...

Full description

Bibliographic Details
Main Authors: Yoshiaki Sato, Kazuto Ueda, Taiki Kondo, Tetsuo Hattori, Alkisti Mikrogeorgiou, Yuichiro Sugiyama, Toshihiko Suzuki, Michiro Yamamoto, Hitoshi Hirata, Akihiro Hirakawa, Keiko Nakanishi, Masahiro Tsuji, Masahiro Hayakawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Neurology
Subjects:
infant
encephalopathy
cell therapy
regenerative medicine
cerebral palsy
mental retardation
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2018.00987/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2018.00987/full

Similar Items